NASDAQ : ABCL
AbCellera Biologics Inc. — Financial statements
Healthcare · Biotechnology · Canada
Last price 12.27 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.98B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
AbCellera Biologics Inc. (ABCL) reported revenue of 66.17M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 66.17M | 75.13M | 28.83M | 38.02M | 485.42M | 375.20M |
| Cost of Revenue | 197.77M | 186.83M | 167.26M | 175.66M | 174.31M | 107.58M |
| Gross Profit | -131.60M | -111.70M | -138.43M | -137.63M | 311.11M | 267.62M |
| Selling, General & Admin | 68.36M | 83.23M | 85.49M | 75.18M | 66.75M | 48.76M |
| Operating Expenses | 93.56M | 105.40M | 144.34M | 99.57M | 86.20M | 63.21M |
| Operating Income | -225.16M | -217.10M | -282.77M | -237.21M | 224.91M | 204.41M |
| Interest & Investment Income | 16.86M | 28.33M | 38.47M | 42.25M | 16.08M | 3.33M |
| Other Non Operating Income (Expenses) | 10.53M | 10.18M | 11.20M | 17.03M | 8.21M | 11.91M |
| EBT Excluding Unusual Items | -197.77M | -178.59M | -233.10M | -177.93M | 249.20M | 219.65M |
| Gain (Loss) on Sale of Investments | 1.00M | 1.00M | 17.40M | 3.90M | -1.70M | -500.00K |
| Asset Writedown | -32.00M | -8.40M | ||||
| Other Unusual Items | 47.30M | |||||
| Pretax Income | -196.77M | -177.59M | -200.40M | -174.03M | 239.10M | 219.15M |
| Income Tax Expense | -32.11M | -31.18M | -37.54M | -27.63M | 80.58M | 65.69M |
| Net Income | -164.66M | -146.41M | -162.86M | -146.40M | 158.52M | 153.46M |
| Net Income to Common | -164.66M | -146.41M | -162.86M | -146.40M | 158.52M | 153.46M |
| Shares Outstanding (Basic) | 301.82M | 298.71M | 294.33M | 289.17M | 285.06M | 275.76M |
| Shares Outstanding (Diluted) | 301.82M | 298.71M | 294.33M | 289.17M | 314.83M | 318.29M |
| EPS (Basic) | -0.55 | -0.49 | -0.55 | -0.51 | 0.56 | 0.56 |
| EPS (Diluted) | -0.55 | -0.49 | -0.55 | -0.51 | 0.50 | 0.48 |
| Free Cash Flow | -119.67M | -174.07M | -186.95M | -120.82M | 206.70M | 186.13M |
| Free Cash Flow Per Share | -0.40 | -0.58 | -0.64 | -0.42 | 0.66 | 0.58 |
| Gross Margin | -198.88% | -148.68% | 64.09% | 71.33% | ||
| Operating Margin | -340.27% | -288.98% | -980.70% | -623.82% | 46.33% | 54.48% |
| Profit Margin | -248.84% | -194.88% | -564.83% | -385.00% | 32.66% | 40.90% |
| Free Cash Flow Margin | -180.85% | -231.69% | -648.40% | -317.75% | 42.58% | 49.61% |
| EBITDA | -199.96M | -194.93M | -223.92M | -212.81M | 244.35M | 218.88M |
| EBITDA Margin | -259.47% | 50.34% | 58.34% | |||
| D&A For EBITDA | 25.20M | 22.17M | 58.85M | 24.39M | 19.44M | 14.46M |
| EBIT | -225.16M | -217.10M | -282.77M | -237.21M | 224.91M | 204.41M |
| EBIT Margin | -288.98% | 46.33% | 54.48% | |||
| Effective Tax Rate | 33.70% | 29.97% | ||||
| Revenue as Reported | 66.17M | 75.13M | 28.83M | 38.02M | 485.42M | 375.20M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 120.06M | 128.51M | 156.32M | 133.32M | 386.54M | 476.14M |
| Short-Term Investments | 420.04M | 405.31M | 469.29M | 627.26M | 499.95M | 246.84M |
| Cash & Short-Term Investments | 540.10M | 533.83M | 625.61M | 760.59M | 886.49M | 722.98M |
| Accounts Receivable | 18.60M | 58.29M | 33.62M | 30.59M | 38.59M | 160.58M |
| Other Receivables | 38.41M | 55.70M | 26.53M | 33.79M | 64.82M | 14.28M |
| Receivables | 95.42M | 153.40M | 92.13M | 64.38M | 103.41M | 174.86M |
| Inventory | 7.58M | 6.34M | 1.53M | 1.67M | ||
| Prepaid Expenses | 11.12M | 9.67M | 8.63M | 22.02M | 9.06M | 5.29M |
| Restricted Cash | 25.00M | 25.00M | 25.00M | 25.00M | 25.00M | 25.00M |
| Total Current Assets | 679.23M | 728.23M | 751.37M | 871.99M | 1.03B | 929.80M |
| Property, Plant & Equipment | 416.68M | 428.00M | 340.43M | 287.70M | 217.25M | 111.62M |
| Long-Term Investments | 91.63M | 94.88M | 114.80M | 65.94M | 34.42M | 32.31M |
| Goodwill | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M | 47.81M |
| Other Intangible Assets | 36.53M | 38.38M | 42.11M | 120.42M | 131.50M | 148.39M |
| Other Long-Term Assets | 35.70M | 19.65M | 34.44M | 80.34M | 40.83M | 30.64M |
| Total Assets | 1.31B | 1.36B | 1.36B | 1.49B | 1.54B | 1.32B |
| Accounts Payable | 12.11M | 25.23M | 34.35M | 28.60M | 14.83M | 14.92M |
| Accrued Expenses | 6.08M | 10.76M | 8.38M | 7.71M | 25.80M | 26.54M |
| Current Portion of Leases | 5.67M | 5.82M | 4.62M | 6.16M | 5.58M | 3.65M |
| Current Income Taxes Payable | 35.68M | |||||
| Current Unearned Revenue | 29.34M | 22.51M | 21.18M | 26.07M | 27.90M | 12.01M |
| Other Current Liabilities | 8.09M | 50.48M | 44.21M | 27.87M | ||
| Total Current Liabilities | 53.19M | 64.31M | 76.61M | 119.01M | 118.32M | 120.68M |
| Long-Term Leases | 129.95M | 137.40M | 60.74M | 71.22M | 76.67M | 36.41M |
| Long-Term Unearned Revenue | 218.70M | 174.45M | 149.89M | 104.11M | 60.32M | 60.76M |
| Long-Term Deferred Tax Liabilities | 9.12M | 10.05M | 30.61M | 33.18M | 37.37M | |
| Other Long-Term Liabilities | 9.71M | 4.77M | 7.17M | 10.82M | 19.14M | 37.62M |
| Total Liabilities | 411.56M | 390.05M | 304.47M | 335.78M | 307.63M | 292.84M |
| Common Stock | 821.24M | 802.34M | 777.17M | 753.20M | 734.37M | 722.43M |
| Additional Paid-In Capital | 206.00M | 198.28M | 166.36M | 121.05M | 74.12M | 35.36M |
| Retained Earnings | -128.07M | -29.48M | 116.93M | 279.79M | 426.19M | 267.67M |
| Comprehensive Income & Other | -3.15M | -4.23M | -4.38M | -1.72M | -1.39M | 280.00K |
| Total Common Equity | 896.02M | 966.90M | 1.06B | 1.15B | 1.23B | 1.03B |
| Shareholders' Equity | 896.02M | 966.90M | 1.06B | 1.15B | 1.23B | 1.03B |
| Total Liabilities & Equity | 1.31B | 1.36B | 1.36B | 1.49B | 1.54B | 1.32B |
| Total Debt | 135.62M | 143.22M | 65.36M | 77.38M | 82.26M | 40.06M |
| Net Cash (Debt) | 404.49M | 390.61M | 560.25M | 683.21M | 804.23M | 682.91M |
| Net Cash Per Share | 1.34 | 1.31 | 1.90 | 2.36 | 2.55 | 2.15 |
| Filing Date Shares Outstanding | 306.61M | 303.16M | 297.99M | 292.78M | 287.69M | 283.92M |
| Total Common Shares Outstanding | 306.47M | 300.60M | 295.76M | 290.82M | 286.85M | 283.26M |
| Working Capital | 626.04M | 663.92M | 674.76M | 752.97M | 907.17M | 809.12M |
| Book Value Per Share | 2.92 | 3.22 | 3.57 | 3.96 | 4.30 | 3.62 |
| Tangible Book Value | 811.68M | 880.72M | 966.16M | 984.09M | 1.05B | 829.53M |
| Tangible Book Value Per Share | 2.65 | 2.93 | 3.27 | 3.38 | 3.67 | 2.93 |
| Land | 53.41M | 53.41M | 53.41M | 53.41M | 53.41M | 33.04M |
| Buildings | 195.07M | 193.16M | 175.81M | 43.95M | 11.36M | 1.21M |
| Machinery | 105.91M | 102.94M | 84.29M | 73.87M | 49.56M | 26.65M |
| Leasehold Improvements | 73.94M | 40.57M | 22.75M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -164.66M | -146.41M | -162.86M | -146.40M | 158.52M | 153.46M |
| Depreciation & Amortization | 32.59M | 28.82M | 65.00M | 30.89M | 24.70M | 17.25M |
| Asset Writedown & Restructuring Costs | 32.00M | 8.40M | ||||
| Stock-Based Compensation | 51.10M | 55.79M | 67.58M | 64.18M | 49.48M | 30.65M |
| Other Operating Activities | 8.15M | 1.20M | -84.44M | -5.78M | 6.43M | 1.55M |
| Change in Accounts Receivable | -17.73M | -55.62M | -75.12M | -45.93M | 106.46M | 22.48M |
| Change in Accounts Payable | -5.81M | 3.46M | 10.63M | -15.10M | -2.09M | -3.24M |
| Change in Unearned Revenue | 26.16M | -5.83M | 26.04M | 25.55M | 15.45M | 39.34M |
| Change in Income Taxes | -30.28M | -29.84M | 6.65M | 30.46M | -88.61M | -13.53M |
| Change in Other Net Operating Assets | 5.54M | 17.15M | 5.95M | 18.25M | -1.38M | -3.38M |
| Operating Cash Flow | -94.94M | -131.29M | -108.56M | -43.88M | 277.36M | 244.58M |
| Capital Expenditures | -24.73M | -42.77M | -78.40M | -76.95M | -70.66M | -58.45M |
| Cash Acquisitions | -11.46M | |||||
| Sale (Purchase) of Intangibles | -2.00M | |||||
| Investment in Securities | 67.50M | 75.91M | 164.10M | -169.47M | -296.40M | -294.96M |
| Other Investing Activities | 55.12M | 54.61M | 35.71M | 25.31M | 16.43M | 32.62M |
| Investing Cash Flow | 97.89M | 87.75M | 121.41M | -221.11M | -352.62M | -332.25M |
| Long-Term Debt Issued | 29.73M | 13.50M | 11.59M | 2.75M | 5.49M | |
| Total Debt Issued | 29.73M | 29.73M | 13.50M | 11.59M | 2.75M | 5.49M |
| Net Debt Issued (Repaid) | 29.73M | 29.73M | 13.50M | 11.59M | 2.75M | 5.49M |
| Other Financing Activities | -4.66M | -15.65M | -729.00K | -1.23M | -4.38M | -9.37M |
| Financing Cash Flow | 25.07M | 14.08M | 12.77M | 10.36M | -1.63M | -3.89M |
| Foreign Exchange Rate Adjustments | -722.00K | 1.10M | -2.62M | 589.00K | -9.60M | -1.43M |
| Net Cash Flow | 27.30M | -28.37M | 23.00M | -254.04M | -86.49M | -92.97M |
| Free Cash Flow | -119.67M | -174.07M | -186.95M | -120.82M | 206.70M | 186.13M |
| Free Cash Flow Margin | -180.85% | -231.69% | -648.40% | -317.75% | 42.58% | 49.61% |
| Free Cash Flow Per Share | -0.40 | -0.58 | -0.64 | -0.42 | 0.66 | 0.58 |
| Levered Free Cash Flow | -46.43M | -176.00M | -177.77M | -102.40M | 205.62M | 143.80M |
| Unlevered Free Cash Flow | -46.43M | -176.00M | -177.77M | -102.40M | 205.62M | 143.80M |
| Change in Working Capital | -22.12M | -70.69M | -25.84M | 13.22M | 29.82M | 41.67M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 3.60B | 1.02B | 865.42M | 1.66B | 2.90B | 4.03B |
| Enterprise Value | 3.20B | 670.27M | 293.68M | 951.79M | 2.11B | 3.30B |
| Last Close Price | 11.12 | 3.42 | 2.93 | 5.71 | 10.13 | 14.30 |
| PE Ratio | 18.28 | 26.24 | ||||
| Forward PE | 60.15 | 60.15 | 60.15 | 60.15 | 51.81 | |
| PS Ratio | 54.46 | 13.63 | 30.02 | 43.57 | 5.97 | 10.73 |
| PB Ratio | 3.80 | 1.06 | 0.82 | 1.44 | 2.35 | 3.93 |
| P/TBV Ratio | 4.44 | 1.16 | 0.90 | 1.68 | 2.75 | 4.85 |
| P/FCF Ratio | 14.02 | 21.63 | ||||
| P/OCF Ratio | 10.45 | 16.46 | ||||
| PEG Ratio | 15.04 | 15.04 | 15.04 | 15.04 | ||
| EV/Sales Ratio | 48.34 | 8.92 | 10.19 | 25.03 | 4.34 | 8.81 |
| EV/EBITDA Ratio | 8.62 | 15.10 | ||||
| EV/EBIT Ratio | 9.36 | 16.17 | ||||
| EV/FCF Ratio | 10.19 | 17.76 | ||||
| Debt / Equity Ratio | 0.15 | 0.15 | 0.06 | 0.07 | 0.07 | 0.04 |
| Debt / EBITDA Ratio | 0.32 | 0.18 | ||||
| Debt / FCF Ratio | 0.40 | 0.21 | ||||
| Net Debt / Equity Ratio | -0.45 | -0.40 | -0.53 | -0.59 | -0.65 | -0.67 |
| Net Debt / EBITDA Ratio | 2.02 | 2.00 | 2.50 | 3.21 | -3.29 | -3.12 |
| Net Debt / FCF Ratio | 3.38 | 2.24 | 3.00 | 5.66 | -3.89 | -3.67 |
| Asset Turnover | 0.05 | 0.06 | 0.02 | 0.03 | 0.34 | 0.32 |
| Inventory Turnover | 108.81 | 69.86 | ||||
| Quick Ratio | 11.23 | 10.07 | 8.95 | 6.93 | 8.37 | 7.44 |
| Current Ratio | 12.77 | 11.32 | 9.81 | 7.33 | 8.67 | 7.71 |
| Return on Equity (ROE) | -17.30% | -14.47% | -14.75% | -12.27% | 14.03% | 16.54% |
| Return on Assets (ROA) | -10.39% | -9.99% | -12.41% | -9.79% | 9.83% | 10.99% |
| Return on Invested Capital (ROIC) | -42.28% | -40.50% | -58.61% | -52.82% | 38.64% | 49.05% |
| Return on Capital Employed (ROCE) | -17.90% | -16.80% | -22.00% | -17.30% | 15.80% | 17.10% |
| Earnings Yield | -4.91% | -14.30% | -18.82% | -8.84% | 5.47% | 3.81% |
| FCF Yield | -3.32% | -17.00% | -21.60% | -7.29% | 7.13% | 4.62% |
| Buyback Yield / Dilution | -1.74% | -1.49% | -1.79% | 8.15% | 1.09% | -20.96% |